EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biologically Informed Radiotherapy in Glioblastoma: A Structured Framework for Imaging-Guided Clinical Decision-Making

Flavio Donnini, Giovanni Rubino, Giuseppe Battaglia, Pierpaolo Pastina, Tommaso Carfagno, Marta Vannini, Alfonso Cerase, Giulio Bagnacci, Armando Perrella, Salvatore Chibbaro, Maria Antonietta Mazzei, Paolo Tini

Radiation · 04.07.2026 · 6 (3) · 25

DOI: 10.3390/radiation6030025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation, online erschienen am 04.07.2026. Verfasst von Flavio Donnini und 11 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy for glioblastoma remains anchored to postoperative structural MRI and anatomy-based target definitions, despite marked spatial heterogeneity and dynamic biological change during chemoradiotherapy. Advanced MRI, amino-acid PET, radiomics, and habitat imaging can characterize tumor biology beyond conventional anatomy, yet their relevance to radiotherapy planning and their evidentiary maturity differ substantially. This narrative review examines the current evidence for biologically informed radiotherapy in glioblastoma and proposes an imaging-based actionability framework that organizes imaging-derived findings into five levels of evidentiary maturity, from descriptive or associative signals to intervention-ready biomarkers, to guide literature interpretation, multidisciplinary discussion, and prospective protocol design. Standard MRI-based planning remains the clinical backbone, supported by contemporary guidelines and the absence of randomized evidence demonstrating benefit from routine biologically guided target modification. Advanced MRI is discussed as the most practical serial platform for treatment-course reassessment, amino-acid PET as a selective complementary tool for metabolic clarification and recurrence assessment, and radiomics and habitat imaging as promising but not yet intervention-ready research layers. Across modalities, prospective evidence supports feasibility more consistently than clinical benefit. The proposed framework is intended to separate biologically informative findings from those sufficiently validated to justify a defined radiotherapy consequence, and to structure the translational path toward intervention-grade evidence in glioblastoma radiotherapy.

Zitieren

APA

Donnini, F., Rubino, G., Battaglia, G., Pastina, P., Carfagno, T., Vannini, M., Cerase, A., Bagnacci, G., Perrella, A., Chibbaro, S., Mazzei, M. A., & Tini, P. (2026). Biologically Informed Radiotherapy in Glioblastoma: A Structured Framework for Imaging-Guided Clinical Decision-Making. Radiation, 6(3), 25. https://doi.org/10.3390/radiation6030025

Vancouver

Donnini F, Rubino G, Battaglia G, Pastina P, Carfagno T, Vannini M, et al. Biologically Informed Radiotherapy in Glioblastoma: A Structured Framework for Imaging-Guided Clinical Decision-Making. Radiation. 2026;6(3):25. doi:10.3390/radiation6030025

BibTeX
@article{Donnini2026,
  author = {Donnini, Flavio and Rubino, Giovanni and Battaglia, Giuseppe and Pastina, Pierpaolo and Carfagno, Tommaso and Vannini, Marta and Cerase, Alfonso and Bagnacci, Giulio and Perrella, Armando and Chibbaro, Salvatore and Mazzei, Maria Antonietta and Tini, Paolo},
  title = {Biologically Informed Radiotherapy in Glioblastoma: A Structured Framework for Imaging-Guided Clinical Decision-Making},
  journal = {Radiation},
  year = {2026},
  volume = {6},
  number = {3},
  pages = {25},
  doi = {10.3390/radiation6030025}
}
Kostenlos starten →